|
2025
|
Invention
|
Reduction of healthcare resource utilization by patients treated with intranasally-administered m... |
|
|
Invention
|
Methods for treating gastroparesis.
Described herein are methods for treating gastroparesis with... |
|
2024
|
Invention
|
Nasal formulations of metoclopramide.
Nasal formulations of metoclopramide, which remain stable ... |
|
2023
|
Invention
|
Novel methods for treating gastroparesis. Described herein are methods for treating gastroparesis... |
|
2022
|
Invention
|
Treatment of moderate and severe gastroparesis. Metoclopramide is administered for the treatment ... |
|
2021
|
Invention
|
Treatment of symptoms associated with female gastroparesis.
Nasal formulations of metoclopramide... |
|
|
Invention
|
Nasal formulations of metoclopramide. Nasal formulations of metoclopramide, which remain stable a... |
|
2020
|
G/S
|
Counseling for patients, namely providing information with respect to patient pharmaceutical reim... |
|
2019
|
G/S
|
pharmaceutical preparations and substances for the prevention, treatment and/or alleviation of ga... |
|
2018
|
Invention
|
Methods of intranasal metoclopramide dosing.
The present disclosure relates to methods of intran... |
|
|
Invention
|
Methods of intranasal metoclopramide dosing. The present disclosure relates to methods of intrana... |
|
2016
|
G/S
|
Pharmaceutical preparations and substances for the prevention, treatment and/or alleviation of ga... |
|
2012
|
Invention
|
Treatment of symptoms associated with female gastroparesis. Nasal formulations of metoclopramide ... |
|
2011
|
G/S
|
Pharmaceutical preparations for the treatment of gastrointestinal diseases Scientific and medical... |
|
2001
|
Invention
|
Nasal administration of agents for the treatment of gastroparesis. The present invention is direc... |
|
1996
|
Invention
|
Nasal administration of agents for treatment of delayed onset emesis. The present invention is di... |
